|
|
Article: PATIENTS, SCIENTISTS PERSEVERE IN GETTING ACTIVASE ON MARKET
- Article from:
- THE JOURNAL RECORD
- Article date:
- March 29, 1989
- Author:
CopyrightCopyright (null) The Journal Record. Provided by ProQuest LLC. (Hide copyright information)
|
It's a long, long step from discovery to market for scientists
who spend their working lives in the search for safe and effective
pharmaceutical products. More often than not, it's one long step
after another.
The development of Activase, a registered thrombolytic agent now
used in the early treatment of heart attacks, is a fascinating case
history.
When administered intraveneously, thrombolytic agents dissolve
blood clots, thus halting or diminishing the severity of heart
attacks. The earlier it's given, the more likely it is the patient
will survive.
First, it's important to recognize the scope of the problems
facing cardiologists and other physicians who intervene at various ...